News Boston Scientific Corporation

Equities

BSX

US1011371077

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 21:00:02 23/06/2025 BST			5-day change	1st Jan Change
102.36 ^USD	+1.05%		+0.86%	+14.60%

06-20	Jefferies Adjusts Price Target on Boston Scientific to $125 From $122	MT
06-16	Leerink Partners Initiates Boston Scientific at Outperform With $118 Price Target	MT

Jefferies Adjusts Price Target on Boston Scientific to $125 From $122	06-20	MT
Leerink Partners Initiates Boston Scientific at Outperform With $118 Price Target	06-16	MT
Worldwide Healthcare Trust trails benchmark in "challenging" year	06-11	AN
Bittium Enters ECG Monitoring Device Deal with Boston Scientific	06-05	MT
Bittium Biosignals Ltd. and Boston Scientific Have Signed an Agreement for the Supply of Electrocardiogram Monitoring Devices	06-04	CI
Bittium's Unit Extends Deal With Boston Scientific	06-04	RE
Inside Information: Bittium Corporation's Subsidiary Bittium Biosignals Ltd. and Boston Scientific Have Signed an Agreement for the Supply of Electrocardiogram Monitoring Devices	06-04	AQ
Goldman Sachs Adjusts Price Target on Boston Scientific to $119 From $117, Maintains Buy Rating	06-02	MT
Health Care Slips as Sector Continues to Lag Market -- Health Care Roundup	05-28	DJ
Sector Update: Health Care Stocks Softer Late Afternoon	05-28	MT
Sector Update: Health Care Stocks Softer Wednesday Afternoon	05-28	MT
Sector Update: Health Care	05-28	MT
Boston Scientific's Farapulse, Watchman to Drive Upside After Acurate's Discontinuation, Needham Says	05-28	MT
Boston Scientific Corporation Presents at Bernstein 41st Annual Strategic Decisions Conference 2025, May-28-2025 08:01 AM	05-28
Boston Scientific Ending Acurate Sales, Approval Efforts -- Update	05-28	DJ
Boston Scientific to stop heart device sales amid regulatory challenges	05-28	RE
Boston Scientific Ends Global Sales of Acurate Valve Systems; Reaffirms Q2, 2025 Sales, Adjusted EPS Guidance	05-28	MT
Boston Scientific Ending Acurate Sales, Approval Efforts	05-28	DJ
Boston Scientific to not seek US approval for heart device amid regulatory challenges	05-28	RE
Citigroup Adjusts Price Target on Boston Scientific to $125 From $119, Maintains Buy Rating	05-22	MT
Morgan Stanley Adjusts Price Target on Boston Scientific to $125 From $120, Maintains Overweight Rating	05-15	MT
Boston Scientific Corporation Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 08:00 AM	05-13
Boston Scientific Insider Sold Shares Worth $477,957, According to a Recent SEC Filing	05-06	MT
Boston Scientific announces upcoming investor conference schedule	05-01	PR
Medical device maker Becton Dickinson cuts 2025 profit forecast on potential tariff hit	05-01	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Boston Scientific: Is the price justified?

January 31, 2025 at 08:26 am